Continuous Infusion of Coagulation Products in Hemophilia
U. Martinowitz, Angelika Bátorová
Abstract
U. Martinowitz, Angelika Bátorová
Abstract
This chapter contains sections titled: Introduction Pharmacokinetic rationale for continuous infusion regimen Essentials for continuous infusion of coagulation factors Guidelines for adjusted-dose continuous infusion and treatment protocols Continuous infusion of FVIII Continuous infusion of factor IX Continuous infusion in the treatment of hemophilia with inhibitor Continuous infusion for long-term prophylaxis Complications of continuous infusion
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Introduction Pharmacokinetic rationale for continuous infusion regimen Essentials for continuous infusion of coagulation factors Guidelines for adjusted-dose continuous infusion and treatment protocols Continuous infusion of FVIII Continuous infusion of factor IX Continuous infusion in the treatment of hemophilia with inhibitor Continuous infusion for long-term prophylaxis Complications of continuous infusion
Key concepts: Continuous infusion, Medicine, Coagulation, Pharmacokinetics, Infusion therapy, Continuous education, Regimen, Continuous monitoring